BackTable / VI / Podcast / Episode #384
New Innovations in Closure Devices
with Dr. Omar Saleh and Dr. Syed Hussain
In this episode, host Dr. Aaron Fritts interviews vascular surgeon Dr. Syed Hussain and interventional radiologist Dr. Omar Saleh about new innovations in closure devices.
BackTable, LLC (Producer). (2023, November 13). Ep. 384 – New Innovations in Closure Devices [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Dr. Omar Saleh
Dr. Omar Saleh is a practicing interventional radiologist with the California Vascular Center.
Dr. Syed Hussain
Dr. Syed Hussain is the chairman of vascular and endovascular surgery at Christie Clinic Vein and Vascular Center in Illinois.
Dr. Aaron Fritts
Dr. Aaron Fritts is a Co-Founder of BackTable and a practicing interventional radiologist in Dallas, Texas.
We begin the episode by discussing how closure devices have evolved over recent years and gained popularity in both hospital and OBL settings. Dr. Hussain and Dr. Saleh highlight the logistical advantages associated with a consistent, reliable closure device. Both doctors speak about their patients’ reported experiences and preferences for different types of closure devices and the importance of having a variety of options at hand.
Dr. Saleh and Dr. Hussain also introduce the new CELT ACD closure device from Vasorum. We learn how to place a CELT, and Dr. Saleh highlights the ease of deployment and the reliability of results. Dr. Hussain also shares his experience in using the CELT, comparing its deployment to a “mic drop”. Additionally, we discuss if there are any potential drawbacks or special considerations that may exist in using CELT compared to other devices.
The doctors cover the time from CELT closure to ambulation/discharge, citing an abstract published in Journal of Vascular Surgery (see resources below). Dr. Hussain and Dr. Saleh also report very few closure-site complications when using CELT, good outcomes with calcified arteries, and ease of bailout options. To conclude the episode, we discuss how physicians can get CELT and other products into their hospital or OBL through the Agency for Healthcare Research and Quality (AHRQ), Consumer Assessment of Healthcare Providers and Systems (CAHPS) scores, and other methods.
Safety and Efficacy of the CELT ACD Femoral Arteriotomy Closure Device in the Office-based Laboratory:
Silent cerebral infarct after cardiac catheterization as detected by diffusion weighted Magnetic Resonance Imaging: a randomized comparison of radial and femoral arterial approaches:
Vasorum CELT ACD Closure Device:
Sponsor Disclaimer: The statements and information provided in this podcast are for educational purposes only, based on the independent and exclusive medical opinions of the physicians, and have not been evaluated by the Food & Drug Administration. The information provided should not be relied upon for medical advice or treatment, as individual patient results may vary. For complete information for the CELT ACT device, including the IFU, contraindications and warnings, please refer to the IFU at www.vasourm.ie for more information.
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.